Developments (Fibretek) was formed in 1988 by Peter Mundell as a Close
Corporation for the development of high duty application fibre-reinforced
composite products. Fibretek was awarded a contract to manufacture under licence
a carbon fibre reinforced attachment medical device used in ligament
1990 the business was registered as a (Pty) Ltd company with other shareholders,
and since then has specialised in the design, manufacture, commercialisation and
marketing of specialised medical devices and instrumentation.
A visual field analyser, the Optoscan was developed by Fibretek and has
been marketed locally and for export since 1990.
1996, the total shareholding of Fibretek was re-acquired
by Peter Mundell, and has since commercialised a neurosurgery guidance system;
the Cape Town Stereotactic Pointer (CTSP), which was developed at the University
of Cape Town. Local
distribution of products has been handled
directly by Fibretek.
Overseas distributors are appointed to market and distribute products,
and in some cases sales are direct to the end user.
in the products stems from their cost competitiveness and
ease of use.
is an accredited ISO 9001 and ISO 13485 company through the
South African Bureau of Standards
quality management auditing
controls are applied to all operations, activities and the products, ensuring
that high quality is maintained throughout all manufacturing, assembly,
calibration and testing processes. Fibretek
prides itself in the after-sales back up, which it offers to its customers and
Fibretek is recognized as offering quality products and is dedicated to
building long-term relationships with customers through quality training and
customer support, both directly and through its distributors.
Phone: +27 44 877 0677
86 617 7311
Mobile: +27 82 552 1060
copyright © 2010 Fibretek